[144] FMC CORP SEC Filing
Rhea-AI Filing Summary
Form 144 notice for FMC (FMC) reports a proposed sale of 3,790 common shares through Fidelity Brokerage Services with an aggregate market value of $128,860, with an approximate sale date of 09/29/2025. The shares were acquired on 09/27/2025 by restricted stock vesting from the issuer and the payment type is listed as compensation. The filing also discloses a prior sale by Jacqueline D. Scanlan of 1,510 shares on 08/18/2025 for gross proceeds of $56,609.90. The notice includes the mandatory representation that the seller does not possess undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive/insider sale notice showing recent vesting and planned sale of a modest share amount.
The filing documents a proposed sale of 3,790 shares valued at $128,860, originating from restricted stock vesting two days earlier and designated as compensation. For investors, this is a standard liquidity event by an insider or recipient of equity compensation rather than a company-disclosed operational event. The recent prior sale of 1,510 shares for $56,609.90 indicates prior limited disposition activity. There is no financial performance data or forward-looking guidance in this filing.
TL;DR: Compliance-focused disclosure consistent with Rule 144; contains required representations about material nonpublic information.
The form identifies the securities, acquisition method (restricted stock vesting), broker, and planned sale date, and reiterates the signers attestation regarding material nonpublic information and Rule 10b5-1 language. This is a routine disclosure to comply with resale and insider-trading regulations. No governance red flags or unusual transaction structures are disclosed in the content provided.